Market Overview:
The global camylofin market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. Camylofin is a drug used for the treatment of various types of pain, such as intestinal colic, biliary colic, renal colic, and dysmenorrhea. The market for camylofin is growing due to the increasing incidence of pain across the globe. Additionally, rising awareness about available treatment options and increasing demand for effective pain relief drugs are also contributing to the growth of this market. On the basis of type, the global camylofin market can be segmented into single drug and mixture drug segments. The single drug segment dominates this market owing to its high efficacy in treating various types of pain when compared with other drugs available in this category. On the basis of application, intestinal colic accounts for majority share in terms of revenue followed by biliary colic and renal colic segments respectively.
Product Definition:
Camylofin is a synthetic, non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation. It is a white to off-white powder with a molecular weight of 273.35 and has the following chemical name: N-(2,6-dimethylphenyl)-4-[(1R,2S)-3-(trifluoromethyl)phenoxy]-1H-pyrazole-3-carboxamide.
Single Drug:
Single drug is a medication which is used for the treatment of one disease only. It’s also known as monoclonal antibody or single-agent medication. Single drug has higher chances of success in comparison to combination drugs due to better understanding of mechanism involved in disease pathogenesis, and this helps researchers & physicians develop novel drugs with improved efficacy & lower adverse effects.
Mixture Drug:
Mixture drug is a combination of two or more active ingredients which are used to treat the same disease with different mechanisms of actions. For instance, Amylin and Nyxol in the U.S., Gevokizumab in Europe, and Bimatoprost and Pilocarpine in India.
Application Insights:
The intestinal colic segment held the largest share of camylofin market in 2017. This is due to high incidence of constipation and sluggish movements in children. The biliary colic segment is expected to witness the fastest growth over the forecast period owing to rising number of biliary disorders, such as cholestasis and jaundice, among infants and children.
Rising awareness about health hazards associated with dysmenorrhea has resulted in increasing prevalence of this condition among women aged 15-19 years across various regions worldwide.
Regional Analysis:
North America dominated the global camylofin market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to increasing incidence of acute and chronic diseases coupled with rising consumer awareness regarding treatment options. In addition, high adoption rate of new technologies and presence of key players are also contributing towards growth in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period due to factors such as improving healthcare infrastructure & availability along with growing patient awareness about available treatment options for various disorders coupled with rising disposable income levels among consumers especially in developing countries like India & China etc.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, arthritis, and diabetes is expected to drive the demand for Camylofin over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth owing to increasing incidence of age-related disorders such as rheumatoid arthritis and osteoarthritis.
- Growing awareness about benefits of Camylofin among healthcare professionals and patients is likely to propel its demand in coming years.
- Technological advancements in drug delivery systems are projected to create new opportunities for Camylofin market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Camylofin Market Research Report
By Type
Single Drug, Mixture Drug
By Application
Intestinal Colic, Biliary Colic, Renal Colic, Dysmenorrhea
By Companies
Merck, Kahira Pharmaceuticals, Winston Pharmaceuticals, Khandelwal Laboratories, Bio Sidus, Astar Pharmaceuticals, Shinlin Sinseng, Bosnalijek, Incopharma, Alkem Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Camylofin Market Report Segments:
The global Camylofin market is segmented on the basis of:
Types
Single Drug, Mixture Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Intestinal Colic, Biliary Colic, Renal Colic, Dysmenorrhea
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Kahira Pharmaceuticals
- Winston Pharmaceuticals
- Khandelwal Laboratories
- Bio Sidus
- Astar Pharmaceuticals
- Shinlin Sinseng
- Bosnalijek
- Incopharma
- Alkem Laboratories
Highlights of The Camylofin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Drug
- Mixture Drug
- By Application:
- Intestinal Colic
- Biliary Colic
- Renal Colic
- Dysmenorrhea
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Camylofin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Camylofin is a medication used to treat psoriasis. It is a topical cream that helps to reduce the inflammation and redness of the skin caused by psoriasis. Camylofin can also help to improve the appearance of scars caused by psoriasis.
Some of the major players in the camylofin market are Merck, Kahira Pharmaceuticals, Winston Pharmaceuticals, Khandelwal Laboratories, Bio Sidus, Astar Pharmaceuticals, Shinlin Sinseng, Bosnalijek, Incopharma, Alkem Laboratories.
The camylofin market is expected to register a CAGR of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Camylofin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Camylofin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Camylofin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Camylofin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Camylofin Market Size & Forecast, 2018-2028
4.5.1 Camylofin Market Size and Y-o-Y Growth
4.5.2 Camylofin Market Absolute $ Opportunity
Chapter 5 Global Camylofin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Camylofin Market Size Forecast by Type
5.2.1 Single Drug
5.2.2 Mixture Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Camylofin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Camylofin Market Size Forecast by Applications
6.2.1 Intestinal Colic
6.2.2 Biliary Colic
6.2.3 Renal Colic
6.2.4 Dysmenorrhea
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Camylofin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Camylofin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Camylofin Analysis and Forecast
9.1 Introduction
9.2 North America Camylofin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Camylofin Market Size Forecast by Type
9.6.1 Single Drug
9.6.2 Mixture Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Camylofin Market Size Forecast by Applications
9.10.1 Intestinal Colic
9.10.2 Biliary Colic
9.10.3 Renal Colic
9.10.4 Dysmenorrhea
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Camylofin Analysis and Forecast
10.1 Introduction
10.2 Europe Camylofin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Camylofin Market Size Forecast by Type
10.6.1 Single Drug
10.6.2 Mixture Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Camylofin Market Size Forecast by Applications
10.10.1 Intestinal Colic
10.10.2 Biliary Colic
10.10.3 Renal Colic
10.10.4 Dysmenorrhea
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Camylofin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Camylofin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Camylofin Market Size Forecast by Type
11.6.1 Single Drug
11.6.2 Mixture Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Camylofin Market Size Forecast by Applications
11.10.1 Intestinal Colic
11.10.2 Biliary Colic
11.10.3 Renal Colic
11.10.4 Dysmenorrhea
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Camylofin Analysis and Forecast
12.1 Introduction
12.2 Latin America Camylofin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Camylofin Market Size Forecast by Type
12.6.1 Single Drug
12.6.2 Mixture Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Camylofin Market Size Forecast by Applications
12.10.1 Intestinal Colic
12.10.2 Biliary Colic
12.10.3 Renal Colic
12.10.4 Dysmenorrhea
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Camylofin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Camylofin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Camylofin Market Size Forecast by Type
13.6.1 Single Drug
13.6.2 Mixture Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Camylofin Market Size Forecast by Applications
13.10.1 Intestinal Colic
13.10.2 Biliary Colic
13.10.3 Renal Colic
13.10.4 Dysmenorrhea
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Camylofin Market: Competitive Dashboard
14.2 Global Camylofin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Kahira Pharmaceuticals
14.3.3 Winston Pharmaceuticals
14.3.4 Khandelwal Laboratories
14.3.5 Bio Sidus
14.3.6 Astar Pharmaceuticals
14.3.7 Shinlin Sinseng
14.3.8 Bosnalijek
14.3.9 Incopharma
14.3.10 Alkem Laboratories
